Industry Reports

Published on: 09/27/2019
Transaction activity involving Aerospace & Defense companies continues to be supported by spending increases in the President’s Budget 2020 growing to $718.3 billion and focusing on innovation and modernization across all warfighting domains.
Published on: 09/25/2019
Leading defense contractors are leveraging buy-and-build strategies to capture prime contracts while also divesting ancillary businesses to become Aerospace & Defense (A&D) pure plays. The continuation of this industry trend is expected to fuel further merger and acquisition (M&A) activity in the Mapping, Modeling & Simulation (MM&S) industry.
Published on: 09/23/2019
As consumer preferences continue to shift towards eco-conscious products, companies creating natural-based personal care products have flourished. Macroeconomic indicators continue to propel M&A growth in the Person Care industry.
Published on: 09/20/2019
The Human Resources & Staffing Services coverage report report discusses the increased demand in the Human Resources and Staffing Services industry which has been driven by heightened labor force participation and shortages of qualified talent.
Published on: 09/20/2019
The Medical Device Outsourcing industry’s strong growth prospects and favorable fundamentals and demographic trends, coupled with the glut of private equity dry powder, is spurring deal activity from financial buyers.
Published on: 09/11/2019
The deployment of digital technologies such as digital health records, telehealth, and artificial intelligence has driven the advancement of the Healthcare Information Technology industry.
Published on: 09/11/2019
Expansion of the HVACR market has resulted from economic growth, the increased availability of tools and products that promote energy efficiency, and the consequential opportunity they create to retrofit building infrastructures.
Published on: 09/09/2019
The rapidly aging U.S. population not only boosts healthcare utilization but reduces the supply of healthcare professionals as aging clinicians retire and choose to work fewer hours.
Published on: 09/09/2019
The increasing volume of gene therapy drugs under development will require greater manufacturing capacity and, in turn, greater utilization of CDMO capacity.  CDMOs may be able to increase penetration of their outsourced manufacturing services by providing services at the commercial stage in addition to the earlier stages of preclinical development and clinical trials.
Published on: 09/09/2019
With Human Capital Management SaaS multiples near historic highs and a very competitive deal environment, it is a great time to be a seller although it remains to be seen how long the window will remain open. 

Pages